These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8122866)

  • 21. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.
    Adamopoulos S; Parissis JT; Iliodromitis EK; Paraskevaidis I; Tsiapras D; Farmakis D; Karatzas D; Gheorghiade M; Filippatos GS; Kremastinos DT
    Am J Cardiol; 2006 Jul; 98(1):102-6. PubMed ID: 16784930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation].
    De Vecchis R; Pucciarelli G; Nocerino L; Cocozza M; Setaro A; Torre G; Imperatore F
    Minerva Cardioangiol; 1998 May; 46(5):163-74. PubMed ID: 9842199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Improved kidney function with intravenous prostaglandin E1 in patients with terminal heart failure].
    Wutte M; Hülsmann M; Berger R; Rödler S; Frey B; Stanek B; Pacher R
    Wien Klin Wochenschr; 1998 Jul; 110(13-14):473-8. PubMed ID: 9746960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE multicenter trial.
    Oliva F; Latini R; Politi A; Staszewsky L; Maggioni AP; Nicolis E; Mauri F
    Am Heart J; 1999 Aug; 138(2 Pt 1):247-53. PubMed ID: 10426835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Home intravenous dobutamine therapy in patients awaiting heart transplantation.
    Collins JA; Skidmore MA; Melvin DB; Engel PJ
    J Heart Transplant; 1990; 9(3 Pt 1):205-8. PubMed ID: 2355273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of three different regimens of intermittent inotrope infusions for end stage heart failure.
    Bonios MJ; Terrovitis JV; Drakos SG; Katsaros F; Pantsios C; Nanas SN; Kanakakis J; Alexopoulos G; Toumanidis S; Anastasiou-Nana M; Nanas JN
    Int J Cardiol; 2012 Sep; 159(3):225-9. PubMed ID: 21481958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Dobutamine therapy at home under the guidance of a nurse practitioner, either as a bridge to cardiac transplantation or as destination therapy in severe heart failure].
    Brügemann J; de Jonge-Weber AT; Rienstra M; van den Broek SA; Zijlstra F; van Veldhuisen DJ
    Ned Tijdschr Geneeskd; 2007 Nov; 151(44):2460-5. PubMed ID: 18064867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Successful use of amrinone in combination with dobutamine in the treatment of severe heart failure].
    Vojtísková J; Málek I; Firt P
    Cas Lek Cesk; 1989 Mar; 128(14):438-43. PubMed ID: 2731213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure.
    Gorodeski EZ; Chu EC; Reese JR; Shishehbor MH; Hsich E; Starling RC
    Circ Heart Fail; 2009 Jul; 2(4):320-4. PubMed ID: 19808355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Improvement of short-term prognosis in patients with refractory heart failure].
    Boffa GM; Cannas S; Cacciavillani L; Marzari A; Grassi G; Bauce B; Livi U; Maddalena F
    G Ital Cardiol; 1997 Oct; 27(10):1024-8. PubMed ID: 9410772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intermittent intravenous amrinone infusion: a potentially cost effective mode of treatment of patients with refractory heart failure.
    Levinoff Roth SN; Moe G
    Can J Cardiol; 1993 Apr; 9(3):231-7. PubMed ID: 8508332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemodynamic effects of levosimendan added to dobutamine in patients with decompensated advanced heart failure refractory to dobutamine alone.
    Nanas JN; Papazoglou PP; Terrovitis JV; Kanakakis J; Dalianis A; Tsolakis E; Tsagalou EP; Agrios N; Christodoulou K; Anastasiou-Nana MI
    Am J Cardiol; 2004 Nov; 94(10):1329-32. PubMed ID: 15541261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
    Kurien S; Warfield KT; Wood CM; Miller WL
    Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term dobutamine therapy for refractory congestive heart failure.
    Pickworth KK
    Clin Pharm; 1992 Jul; 11(7):618-24. PubMed ID: 1617912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intermittent infusion of dobutamine in the therapy of severe congestive heart failure--long-term effects and lack of tolerance.
    Erlemeier HH; Kupper W; Bleifeld W
    Cardiovasc Drugs Ther; 1992 Aug; 6(4):391-8. PubMed ID: 1520649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Perioperative management of two patients with severe dilated cardiomyopathy].
    Otani S; Fujii H; Kurasaka N; Ishizu T; Tanaka T; Kousogabe Y; Tokioka H
    Masui; 1998 Feb; 47(2):200-3. PubMed ID: 9513335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency.
    Usmanov RI; Zueva EB; Silverberg DS; Shaked M
    J Nephrol; 2008; 21(2):236-42. PubMed ID: 18446719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Normalization of ejection fraction and resolution of symptoms in chronic severe heart failure is possible with modern medical therapy: clinical observations in 11 patients.
    Harinstein ME; Berliner JI; Shah SJ; Taegtmeyer H; Gheorghiade M
    Am J Ther; 2008; 15(3):206-13. PubMed ID: 18496257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Safety and tolerability of beta-blockers in severe cardiac decompensation from dilated cardiomyopathy].
    Sinagra G; Perkan A; Zecchin M; Di Lenarda A; Lardieri G; Rakar S; Secoli G; Pinamonti B; Camerini F
    G Ital Cardiol; 1995 Oct; 25(10):1255-63. PubMed ID: 8682221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic electrical stimulation during the absolute refractory period of the myocardium improves severe heart failure.
    Stix G; Borggrefe M; Wolpert C; Hindricks G; Kottkamp H; Böcker D; Wichter T; Mika Y; Ben-Haim S; Burkhoff D; Wolzt M; Schmidinger H
    Eur Heart J; 2004 Apr; 25(8):650-5. PubMed ID: 15084369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.